The effect of systemic and ovarian infusion of glucose, galactose and fructose on ovarian function in sheep.
Glucose is a critical metabolic fuel in most mammals although many foodstuffs also contain high levels of the monosaccharides, galactose and fructose. The aims of this work were to determine the insulin response to challenges of these sugars (experiment 1) and to examine the effect of systemic (experiment 2) and direct ovarian (experiment 3) infusion of these monosaccharides on ovarian function in ewes with autotransplanted ovaries. In experiment 1, both fructose (fourfold increase peaking in 2 h) and galactose (twofold increase; 30 min) elicited markedly different (P<0.001) insulin responses than glucose (sevenfold increase; 20 min) although the total amount released following fructose and glucose challenge was similar. In experiment 2, low-dose systemic fructose infusion had no acute effect on insulin but did depress FSH (P<0.05), and following the end of fructose infusion, a transient increase in FSH and insulin was observed (P<0.05), which was associated with an increase (P<0.05) in ovarian oestradiol and androstenedione secretion. Systemic infusion of neither glucose nor galactose had a significant effect on ovarian steroidogenesis although glucose acutely suppressed insulin levels. In contrast, ovarian arterial infusion of fructose and glucose had no effect on ovarian function whereas galactose suppressed ovarian follicle number and steroid secretion (P<0.05). In conclusion, this work indicates that fructose and galactose can influence ovarian function in vivo in sheep and that different mechanisms are involved. Thus, fructose exerts stimulatory effects through indirect modulation of peripheral insulin and/or gonadotrophin levels whereas galactose exerts primarily suppressive effects by direct actions on the ovary.
Campbell
B K
BK
Division of Human Development, School of Clinical Sciences, University of Nottingham, Q.M.C., Nottingham NG7 2UH, UK. bruce.campbell@nottingham.ac.uk
Kendall
N R
NR
Onions
V
V
Scaramuzzi
R J
RJ
D000735:Androstenedione / Q000097:blood; D000818:Animals; D018592:Cross-Over Studies; D004958:Estradiol / Q000097:blood; D005260:Female; D005640:Follicle Stimulating Hormone / Q000097:blood; D005632:Fructose / Q000008:administration & dosage / Q000097:blood / Q000378:metabolism*; D005690:Galactose / Q000008:administration & dosage / Q000097:blood / Q000378:metabolism*; D005947:Glucose / Q000008:administration & dosage / Q000032:analysis / Q000378:metabolism*; D007328:Insulin / Q000097:blood / Q000378:metabolism*; D007986:Luteinizing Hormone / Q000097:blood; D010053:Ovary / Q000000981:diagnostic imaging / Q000378:metabolism*; D011374:Progesterone / Q000097:blood; D012756:Sheep / Q000378:metabolism*; D014463:Ultrasonography
D007328:Insulin; D005632:Fructose; D000735:Androstenedione; D011374:Progesterone; D004958:Estradiol; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone; D005947:Glucose; D005690:Galactose